A group of angels turns up their nose at a company making a useful, well-targeted and well-validated computer peripheral product. The smart entrepreneur behind the company asks a pretty fundamental question in response: “Why do angel investors often turn up their noses at real, down-to-earth physical product companies and instead chase ethereal web and process flow services businesses?”
- Clinical Trial Confirms GammaTile Superior Tumor Control
- 2025 Brutal Biotech Investment Climate
- Delta Development Team – Introducing BloodCOMM Premium
- Special Operations Forces Blood Cooler from Delta Development
- UACI startup alumni Reglagene making impressive strides in brain cancer treatment
- Reglagene RGN6024 Cover Story August 2025 Molecular Cancer Therapeutics
- Calls for More Angel Investing
- Takes a Licking and Keeps on Ticking
- Ventura County firefighters make history with in-the-field blood transfusions
- FireRescue1’s “3 Things We’re Watching at FDIC 2025